Evidence map›Paper›PMID 23389033›Full record

ArticleThe Journal of biological chemistry2013

MicroRNA-140 promotes adipocyte lineage commitment of C3H10T1/2 pluripotent stem cells via targeting osteopetrosis-associated transmembrane protein 1.

Yuan Liu, Zhi-Chun Zhang, Shu-Wen Qian, You-You Zhang, Hai-Yan Huang, Yan Tang, Liang Guo, Xi Li, Qi-Qun Tang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuan LiuKey Laboratory of Molecular Medicine, Ministry of Education, and the Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai 200032, China; Institute of Stem Cell Research and Regenerative Medicine, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Zhi-Chun ZhangKey Laboratory of Molecular Medicine, Ministry of Education, and the Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai 200032, China.
Shu-Wen QianKey Laboratory of Molecular Medicine, Ministry of Education, and the Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai 200032, China; Institute of Stem Cell Research and Regenerative Medicine, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
You-You ZhangInstitute of Stem Cell Research and Regenerative Medicine, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Hai-Yan HuangKey Laboratory of Molecular Medicine, Ministry of Education, and the Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai 200032, China; Institute of Stem Cell Research and Regenerative Medicine, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Yan TangKey Laboratory of Molecular Medicine, Ministry of Education, and the Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai 200032, China.
Liang GuoKey Laboratory of Molecular Medicine, Ministry of Education, and the Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai 200032, China.
Xi LiKey Laboratory of Molecular Medicine, Ministry of Education, and the Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai 200032, China; Institute of Stem Cell Research and Regenerative Medicine, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China. Electronic address: lixi@shmu.edu.cn.
Qi-Qun TangKey Laboratory of Molecular Medicine, Ministry of Education, and the Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai 200032, China; Institute of Stem Cell Research and Regenerative Medicine, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China. Electronic address: qqtang@shmu.edu.cn.
Shanghai Medical College of Fudan University · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BMP4 has been shown to induce C3H10T1/2 pluripotent stem cells to commit to adipocyte lineage. In addition to several proteins identified, microRNAs also play a critical role in the process. In this study, we identified microRNA-140 (miR-140) as a direct downstream component of the BMP4 signaling pathway during the commitment of C3H10T1/2 cells to adipocyte lineage. Overexpression of miR-140 in C3H10T1/2 cells promoted commitment, whereas knockdown of its expression led to impairment. Additional studies indicated that Ostm1 is a bona fide target of miR-140, which is significantly decreased during commitment, and Ostm1 was also demonstrated to function as an anti-adipogenic factor.

Indexed as

RNA Interference3T3-L1 CellsAdipocytesAdipogenesisAnimalsBase SequenceBone Morphogenetic Protein 4Membrane ProteinsMiceMice, Inbred C3HMicroRNAsPluripotent Stem CellsTranscriptional ActivationBmp4 protein, mouseBone Morphogenetic Protein 4Membrane ProteinsMicroRNAsMIRN140 microRNA, mouseOSTM1 protein, mouse

Identifiers

PMID23389033
PMCPMC3605640
OpenAlexW2111333347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.